Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Enterprise Value (2016 - 2025)

AtriCure (ATRC) has disclosed Enterprise Value for 16 consecutive years, with -$167.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 36.43% to -$167.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$167.4 million, a 36.43% decrease, with the full-year FY2025 number at -$167.4 million, down 36.43% from a year prior.
  • Enterprise Value was -$167.4 million for Q4 2025 at AtriCure, down from -$147.9 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$99.9 million in Q1 2025 to a low of -$227.2 million in Q1 2021.
  • A 5-year average of -$131.9 million and a median of -$122.7 million in 2022 define the central range for Enterprise Value.
  • Biggest YoY gain for Enterprise Value was 51.24% in 2021; the steepest drop was 231.51% in 2021.
  • AtriCure's Enterprise Value stood at -$119.1 million in 2021, then dropped by 1.7% to -$121.1 million in 2022, then fell by 13.35% to -$137.3 million in 2023, then rose by 10.61% to -$122.7 million in 2024, then tumbled by 36.43% to -$167.4 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Enterprise Value are -$167.4 million (Q4 2025), -$147.9 million (Q3 2025), and -$117.8 million (Q2 2025).